Exhibit 99.3
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
On April 22, 2015, ARRIS Group, Inc. (“ARRIS”) announced its proposed combination (the “Combination”) with Pace plc, a company incorporated in England and Wales (“Pace”). In connection with the Combination, (i) ARRIS International plc (formerly ARRIS International Limited) (“New ARRIS”), a company incorporated in England and Wales and wholly-owned subsidiary of ARRIS Group, agreed to acquire all of the outstanding ordinary shares of Pace by means of court-sanctioned scheme of arrangement (the “Scheme”) under English law (the “Pace Acquisition”) and (ii) ARRIS entered into a Merger Agreement (the “Merger Agreement”), dated April 22, 2015, among ARRIS, New ARRIS, ARRIS US Holdings, Inc. (formerly Archie U.S. Holdings LLC) (“ARRIS Holdings”), a Delaware corporation and wholly-owned subsidiary of New ARRIS (“US Holdco”) and Archie U.S. Merger LLC, a Delaware limited liability company and wholly-owned subsidiary of US Holdco (“Merger Sub”), providing that immediately upon the Pace Acquisition, Merger Sub would be merged with and into ARRIS (the “Merger”), with ARRIS surviving the Merger as an indirect wholly-owned subsidiary of New ARRIS. On January 4, 2016, ARRIS completed the Combination.
The following unaudited pro forma condensed combined financial information has been prepared to illustrate the effect of the following: (i) the Combination; and (ii) the refinancing of ARRIS’ existing Term Loan A Facility and Revolving Credit Facility and the incurrence of $800.0 million of indebtedness under the Term A-1 Loan Facility (collectively referred to as the “Financing”).
The following unaudited pro forma condensed combined financial information gives effect to the Combination under the acquisition method of accounting in accordance with Financial Accounting Standards Board (FASB) Accounting Standard Codification (ASC) Topic 805, Business Combinations, which we refer to as ASC 805, with ARRIS treated as the accounting acquirer. The historical consolidated financial information has been adjusted in the unaudited pro forma condensed combined financial information to give effect to pro forma events that are (1) directly attributable to the Combination and Financing, (2) factually supportable and (3) with respect to the statements of operations, expected to have a continuing impact on the combined results of ARRIS and Pace.
The unaudited pro forma condensed combined balance sheet is based on the historical consolidated balance sheets of ARRIS as of September 30, 2015 and Pace as of June 30, 2015, and has been prepared to reflect the Combination and the incurrence of $800 million of indebtedness under the Term A-1 Loan Facility as if they occurred on September 30, 2015. The unaudited pro forma condensed combined statements of operations for the year ended December 31, 2014 and the nine months ended September 30, 2015 combine the historical results of operations of ARRIS and Pace, giving effect to the Combination and Financing as if they occurred on January 1, 2014. The unaudited pro forma condensed combined balance sheet at September 30, 2015 utilizes the consolidated balance sheet of ARRIS as of September 30, 2015 and the consolidated balance sheet of Pace as of June 30, 2015. The unaudited pro forma condensed statement of operations for the year ended December 31, 2014 utilizes the historical results of ARRIS and Pace for the year ended December 31, 2014, respectively, the most recent available consolidated financial statements. The unaudited pro forma condensed statement of operations for the nine months ended September 30, 2015 utilizes the consolidated historical results of ARRIS for the nine months ended September 30, 2015 and the nine months ended June 30, 2015 for Pace. As such, these results are not necessarily indicative of the actual results at September 30, 2015 and for the nine months ended September 30, 2015 since the three-month period ended December 31, 2014 is included in the Pace’s nine months ended June 30, 2015 results are higher due to trading performance differences.
The unaudited pro forma condensed combined statements of operations do not reflect future events that may occur after the Combination, including, but not limited to, the anticipated realization of ongoing savings from operating synergies and certain one-time charges New ARRIS expects to incur in connection with the Combination, including, but not limited to, costs in connection with integrating the operations of ARRIS and Pace.
26
This unaudited pro forma condensed combined financial information is for informational purposes only. It does not purport to indicate the results that would actually have been obtained had the Combination and Financing been completed on the assumed date or for the periods presented, or which may be realized in the future.
To produce the pro forma financial information, ARRIS adjusted Pace’s assets and liabilities to their estimated fair values. As of the date of this filing, ARRIS has not completed the detailed valuation work necessary to arrive at the required estimates of the fair value of the Pace assets acquired and the liabilities assumed and the related accounting for the business combination, nor has it identified all adjustments necessary to conform Pace’s accounting policies to ARRIS’ accounting policies. Accordingly, the accompanying unaudited pro forma accounting for the business combination is preliminary and is subject to further adjustments as additional information becomes available and additional analyses are performed. The preliminary unaudited pro forma accounting for the business combination has been made solely for the purpose of preparing the accompanying unaudited pro forma condensed combined financial information. In accordance with ASC 805, the assets acquired and the liabilities assumed have been measured at preliminary estimates of fair value. These preliminary estimates are based on key assumptions related to the Combination and have been developed using publicly disclosed information for other acquisitions in the industry, ARRIS’ historical experience and current available data. As the valuation work is being completed, any increases or decreases in the fair value of relevant statement of financial position amounts will result in adjustments to the balance sheet and/or statements of operations until the accounting for the business combination is finalized.
There can be no assurance that such finalization will not result in material changes from the preliminary accounting for the business combination included in the accompanying unaudited pro forma condensed combined financial information. The unaudited pro forma condensed combined financial information has been derived from and should be read in conjunction with:
• | New ARRIS’ Current Report on Form 8-K filed with the SEC on January 4, 2016, as amended by Current Report on Form 8-K/A Amendment No. 1 (the “Form 8-K/A”) of which these unaudited pro forma condensed combined financial statements are included as Exhibit 99.3; |
• | The accompanying notes to the unaudited pro forma condensed combined financial information; |
• | ARRIS’ audited consolidated financial statements and related notes thereto contained in its Annual Report on Form 10-K for the year ended December 31, 2014 and ARRIS’ unaudited consolidated financial statements and related notes thereto contained in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2015; and |
• | Pace’s audited consolidated financial statements and related notes thereto for the years ended December 31, 2014, 2013 and 2012 are incorporated by reference to New ARRIS’ Registration Statement on Form S-4 filed with the Commission on September 11, 2015 (File No. 333-205442). Pace’s unaudited consolidated financial statements and related notes hereto for the six months period ended June 30, 2015 are included in Exhibit 99.2 to the Form 8K/A. |
27
NEW ARRIS
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
As of September 30, 2015(1)
($ in thousands, except per share data)
Pace | ||||||||||||||||||||||||||||
Historical ARRIS | Historical (IFRS) | Accounting Policies and Reclassifications (Note 3) | US GAAP Adjustments (Note 4) | Historical (US GAAP) | Pro Forma Adjustments (Note 6) | New ARRIS Pro Forma Condensed Combined | ||||||||||||||||||||||
ASSETS | ||||||||||||||||||||||||||||
Current assets: | ||||||||||||||||||||||||||||
Cash and cash equivalents | $ | 673,346 | $ | 254,162 | $ | — | $ | — | $ | 254,162 | $ | 129,869 | (a) | $ | 1,057,377 | |||||||||||||
Short-term investments, at fair value | 107,777 | — | — | — | — | — | 107,777 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Total cash, cash equivalents and short-term investments | 781,123 | 254,162 | — | — | 254,162 | 129,869 | 1,165,154 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Accounts receivable (net of allowances for doubtful accounts) | 647,726 | — | 530,069 | 21,959 | 552,028 | — | 1,199,754 | |||||||||||||||||||||
Trade and other receivables | — | 582,833 | (582,833 | ) | — | — | — | — | ||||||||||||||||||||
Other receivables | 8,684 | — | 41,577 | — | 41,577 | — | 50,261 | |||||||||||||||||||||
Inventories (net of reserves) | 367,536 | 237,627 | — | — | 237,627 | 33,600 | (b) | 638,763 | ||||||||||||||||||||
Prepaid income taxes | 29,071 | 6,068 | — | — | 6,068 | — | 35,139 | |||||||||||||||||||||
Prepaids | 26,430 | — | 11,187 | — | 11,187 | — | 37,617 | |||||||||||||||||||||
Current deferred income tax assets | 104,345 | — | — | 40,855 | 40,855 | — | 145,200 | |||||||||||||||||||||
Other current assets | 153,527 | — | — | 83,937 | 83,937 | — | 237,464 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Total current assets | 2,118,442 | 1,080,690 | — | 146,751 | 1,227,441 | 163,469 | 3,509,352 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Property, plant and equipment (net of accumulated depreciation) | 319,443 | 57,813 | — | — | 57,813 | 40,558 | (c) | 417,814 | ||||||||||||||||||||
Goodwill | 1,016,696 | 464,806 | — | — | 464,806 | 645,306 | (d) | 2,126,808 | ||||||||||||||||||||
Intangible assets (net of accumulated amortization) | 868,054 | 272,050 | — | (87,850 | ) | 184,200 | 915,800 | (e) | 1,968,054 | |||||||||||||||||||
Investments | 74,924 | — | — | — | — | — | 74,924 | |||||||||||||||||||||
Noncurrent deferred income tax assets | 70,557 | 27,488 | — | (21,186 | ) | 6,302 | — | 76,859 | ||||||||||||||||||||
Other assets | 45,124 | — | — | — | — | (938 | ) (f) | 44,186 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
TOTAL ASSETS | $ | 4,513,240 | $ | 1,902,847 | $ | — | $ | 37,715 | $ | 1,940,562 | $ | 1,764,195 | $ | 8,217,997 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||||||||||||||||||||||
Current liabilities: | ||||||||||||||||||||||||||||
Accounts payable | $ | 558,371 | $ | — | $ | 559,499 | $ | — | $ | 559,499 | $ | — | $ | 1,117,870 | ||||||||||||||
Trade and other payables | — | 704,060 | (704,060 | ) | — | — | — | — | ||||||||||||||||||||
Accrued compensation, benefits and related taxes | 97,326 | — | 16,962 | — | 16,962 | — | 114,288 | |||||||||||||||||||||
Accrued warranty | 35,488 | — | 27,200 | — | 27,200 | — | 62,688 | |||||||||||||||||||||
Deferred revenue | 97,490 | — | 4,016 | 139,677 | 143,693 | (122,349 | ) (g) | 118,834 | ||||||||||||||||||||
Current portion of long-term debt and financing lease obligations | 48,647 | 41,362 | — | 21,959 | 63,321 | 39,304 | (j) | 151,272 | ||||||||||||||||||||
Current income taxes liability | 13,139 | 10,728 | — | (7,184 | ) | 3,544 | 55,000 | (h) | 71,683 | |||||||||||||||||||
Other accrued liabilities | 168,870 | 33,483 | 96,383 | (43,700 | ) | 86,166 | 58,626 | (i) | 313,662 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Total current liabilities | 1,019,331 | 789,633 | — | 110,752 | 900,385 | 30,581 | 1,950,297 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Long-term debt and financing lease obligations, net of current portion | 1,525,454 | 215,115 | — | — | 215,115 | 757,453 | (j) | 2,498,022 | ||||||||||||||||||||
Accrued pension | 67,570 | — | — | — | — | — | 67,570 | |||||||||||||||||||||
Noncurrent income tax liability | 38,145 | — | — | 9,055 | 9,055 | — | 47,200 | |||||||||||||||||||||
Noncurrent deferred income tax liabilities | 329 | 83,930 | — | (10,957 | ) | 72,973 | 277,344 | (k) | 350,646 | |||||||||||||||||||
Other noncurrent liabilities | 71,560 | 85,404 | — | — | 85,404 | — | 156,964 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Total liabilities | 2,722,389 | 1,174,082 | — | 108,850 | 1,282,932 | 1,065,378 | 5,070,699 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Stockholders’ equity: | ||||||||||||||||||||||||||||
Preferred stock, par value $1.00 per share, | — | — | — | — | — | — | — | |||||||||||||||||||||
Common and ordinary shares | 1,819 | 29,528 | — | — | 29,528 | (27,971 | ) (l) | 3,376 | ||||||||||||||||||||
Capital in excess of par value | 1,762,111 | 196,432 | — | 1,887 | 198,319 | 910,336 | (l) | 2,870,766 | ||||||||||||||||||||
Treasury stock at cost | (331,329 | ) | — | — | — | — | 331,329 | (l) | — | |||||||||||||||||||
Retained earnings | 328,782 | 595,614 | — | (73,470 | ) | 522,144 | (607,238 | ) (l) | 243,688 | |||||||||||||||||||
Accumulated other comprehensive loss | (20,236 | ) | (92,809 | ) | — | 448 | (92,361 | ) | 92,361 | (l) | (20,236 | ) | ||||||||||||||||
Stockholders’ equity attributable to noncontrolling interest | 49,704 | — | — | — | — | — | 49,704 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Total stockholders’ equity | 1,790,851 | 728,765 | — | (71,135 | ) | 657,630 | 698,817 | 3,147,298 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 4,513,240 | $ | 1,902,847 | $ | — | $ | 37,715 | $ | 1,940,562 | $ | 1,764,195 | $ | 8,217,997 | ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | The unaudited pro forma condensed combined balance sheet at September 30, 2015 includes the historical results of Pace at June 30, 2015. |
See accompanying Notes to Unaudited Pro Forma Condensed Combined Financial Information
28
NEW ARRIS
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
Year Ended December 31, 2014
($ in thousands, except per share data)
Pace | ||||||||||||||||||||||||||||
Historical ARRIS | Historical (IFRS) | Accounting Policies and Reclassifications (Note 3) | US GAAP Adjustments (Note 4) | Historical (US GAAP) | Pro Forma Adjustments (Note 6) | New ARRIS Pro Forma Condensed Combined | ||||||||||||||||||||||
Net sales | $ | 5,322,921 | $ | 2,620,030 | $ | — | $ | (90,855 | ) | $ | 2,529,175 | $ | — | $ | 7,852,096 | |||||||||||||
Cost of sales | 3,740,425 | 2,087,601 | (1,497 | ) | (73,319 | ) | 2,012,785 | (96 | ) (m) | 5,753,114 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Gross margin | 1,582,496 | 532,429 | 1,497 | (17,536 | ) | 516,390 | 96 | 2,098,982 | ||||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||||
Selling, general and administrative expenses | 410,568 | 161,981 | (535 | ) | — | 161,446 | (91 | ) (n) | 571,923 | |||||||||||||||||||
Research and development expenses | 556,575 | 129,316 | (4 | ) | 20,760 | 150,072 | (100 | ) (o) | 706,547 | |||||||||||||||||||
Amortization of intangible assets | 236,521 | 52,936 | — | — | 52,936 | 143,451 | (p) | 432,908 | ||||||||||||||||||||
Integration, acquisition, restructuring and other costs | 37,498 | 7,356 | — | — | 7,356 | — | 44,854 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Total operating expenses | 1,241,162 | 351,589 | (539 | ) | 20,760 | 371,810 | 143,260 | 1,756,232 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Operating income | 341,334 | 180,840 | 2,036 | (38,296 | ) | 144,580 | (143,164 | ) | 342,750 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Other expense (income): | ||||||||||||||||||||||||||||
Interest expense | 62,901 | 7,702 | — | — | 7,702 | 11,179 | (r) | 81,782 | ||||||||||||||||||||
Loss on investments | 10,961 | — | — | — | — | — | 10,961 | |||||||||||||||||||||
Loss (gain) on foreign currency | 2,637 | — | 6,207 | — | 6,207 | — | 8,844 | |||||||||||||||||||||
Interest income | (2,590 | ) | (2,542 | ) | — | — | (2,542 | ) | — | (5,132 | ) | |||||||||||||||||
Other expense, net | 28,195 | — | (4,171 | ) | — | (4,171 | ) | — | 24,024 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Income before income taxes | 239,230 | 175,680 | — | (38,296 | ) | 137,384 | (154,343 | ) | 222,271 | |||||||||||||||||||
Income tax expense (benefit) | (87,981 | ) | 27,666 | — | (10,327 | ) | 17,339 | (44,759 | ) (s) | (115,401 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Net income | $ | 327,211 | $ | 148,014 | $ | — | $ | (27,969 | ) | $ | 120,045 | $ | (109,584 | ) | $ | 337,672 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Net income per common share: | ||||||||||||||||||||||||||||
Basic | $ | 2.27 | $ | 0.47 | $ | 1.75 | ||||||||||||||||||||||
|
|
|
|
|
| |||||||||||||||||||||||
Diluted | $ | 2.21 | $ | 0.46 | $ | 1.72 | ||||||||||||||||||||||
|
|
|
|
|
| |||||||||||||||||||||||
Weighted average common shares | ||||||||||||||||||||||||||||
Basic | 144,386 | 312,335 | 48,705 | (t) | 193,091 | |||||||||||||||||||||||
|
|
|
|
|
|
|
| |||||||||||||||||||||
Diluted | 148,280 | 324,475 | 48,116 | (t) | 196,396 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
See accompanying Notes to Unaudited Pro Forma Condensed Combined Financial Information
29
NEW ARRIS
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
Nine Months Ended September 30, 2015 (1)
($ in thousands, except per share data)
Pace | ||||||||||||||||||||||||||||
Historical ARRIS | Historical (IFRS) | Accounting Policies and Reclassifications (Note 3) | US GAAP Adjustments (Note 4) | Historical (US GAAP) | Pro Forma Adjustments (Note 6) | New ARRIS Pro Forma Condensed Combined | ||||||||||||||||||||||
Net sales | $ | 3,696,650 | �� | $ | 2,107,692 | $ | — | $ | (92,101 | ) | $ | 2,015,591 | $ | — | $ | 5,712,241 | ||||||||||||
Cost of sales | 2,636,400 | 1,662,162 | (3,208 | ) | (76,916 | ) | 1,582,038 | 247 | (m) | 4,218,685 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Gross margin | 1,060,250 | 445,530 | 3,208 | (15,185 | ) | 433,553 | (247 | ) | 1,493,556 | |||||||||||||||||||
Operating expenses: | ||||||||||||||||||||||||||||
Selling, general and administrative expenses | 309,219 | 113,452 | (2,201 | ) | — | 111,251 | 232 | (n) | 420,702 | |||||||||||||||||||
Research and development expenses | 400,932 | 92,409 | 1,720 | 8,013 | 102,142 | 256 | (o) | 503,330 | ||||||||||||||||||||
Amortization of intangible assets | 171,062 | 37,092 | — | — | 37,092 | 110,198 | (p) | 318,352 | ||||||||||||||||||||
Integration, acquisition, restructuring and other costs | 20,996 | 7,156 | — | — | 7,156 | (19,254 | ) (q) | 8,898 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Total operating expenses | 902,209 | 250,109 | (481 | ) | 8,013 | 257,641 | 91,432 | 1,251,282 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Operating income | 158,041 | 195,421 | 3,689 | (23,198 | ) | 175,912 | (91,679 | ) | 242,274 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Other expense (income): | ||||||||||||||||||||||||||||
Interest expense | 56,570 | 5,834 | — | — | 5,834 | (4,149 | ) (r) | 58,255 | ||||||||||||||||||||
Loss on investments | 6,565 | — | — | — | — | — | 6,565 | |||||||||||||||||||||
Loss (gain) on foreign currency | 4,204 | — | 6,273 | — | 6,273 | — | 10,477 | |||||||||||||||||||||
Interest income | (1,792 | ) | (1,197 | ) | — | — | (1,197 | ) | — | (2,989 | ) | |||||||||||||||||
Other expense, net | 5,170 | — | (2,584 | ) | — | (2,584 | ) | — | 2,586 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Income before income taxes | 87,324 | 190,784 | — | (23,198 | ) | 167,586 | (87,530 | ) | 167,380 | |||||||||||||||||||
Income tax expense (benefit) | 29,710 | 11,230 | — | (9,921 | ) | 1,309 | (25,384 | ) (s) | 5,635 | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Consolidated net income | 57,614 | 179,554 | — | (13,277 | ) | 166,277 | (62,146 | ) | 161,745 | |||||||||||||||||||
Net loss attributable to noncontrolling interests | (4,526 | ) | — | — | — | — | — | (4,526 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Net income | $ | 62,140 | $ | 179,554 | $ | — | $ | (13,277 | ) | $ | 166,277 | $ | (62,146 | ) | $ | 166,271 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Net income per common share: | ||||||||||||||||||||||||||||
Basic | $ | 0.43 | $ | 0.57 | $ | 0.85 | ||||||||||||||||||||||
|
|
|
|
|
| |||||||||||||||||||||||
Diluted | $ | 0.42 | $ | 0.55 | $ | 0.84 | ||||||||||||||||||||||
|
|
|
|
|
| |||||||||||||||||||||||
Weighted average common shares | ||||||||||||||||||||||||||||
Basic | 146,146 | 313,996 | 48,705 | (t) | 194,851 | |||||||||||||||||||||||
|
|
|
|
|
|
|
| |||||||||||||||||||||
Diluted | 149,232 | 325,227 | 48,023 | (t) | 197,255 | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
(1) | The unaudited pro forma condensed combined statement of operations for the nine months ended September 30, 2015 includes the historical results of Pace the nine months ended June 30, 2015. |
See accompanying Notes to Unaudited Pro Forma Condensed Combined Financial Information
30
NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
1. Description of Combination and Financing
On April 22, 2015, the boards of ARRIS and Pace reached agreement on the terms of the Combination which closed on January 4, 2016, whereby (i) New ARRIS acquired all of the outstanding shares of Pace by means of a court-sanctioned scheme of arrangement under English law and (ii) ARRIS merged with a subsidiary of New ARRIS, with ARRIS surviving the Merger (pursuant to the Merger Agreement). Under the terms of the Combination, (a) Pace Scheme shareholders received 132.5 pence in cash and 0.1455 shares of New ARRIS for each Pace share they held and (b) ARRIS stockholders received one New ARRIS share for each share of ARRIS common stock they held. As the result of the completion of the Combination, Pace shareholders own approximately 24% of issued share capital of New ARRIS on a fully diluted basis and ARRIS stockholders own approximately 76% of the issued share capital of New ARRIS on a fully diluted basis. New ARRIS ordinary shares are listed on NASDAQ under the symbol ARRS. The Combination values the entire share capital of Pace at approximately $2,073.5 million at an opening share price of $30.08 on January 4, 2016 and an exchange rate of 1.4707.
At the closing date, certain awards of Pace stock options, deferred shares and performance shares were canceled and converted into the right to receive 132.5 pence in cash, without interest, and 0.1455 of New ARRIS shares for each Pace award they hold. New ARRIS included as consideration $72.2 million for the fair value of the awards related to pre-combination services including (i) vested stock options, performance shares and deferred shares; (ii) deferred shares for which vesting was accelerated as a result of the change in control provision in the Deferred Share Plan; and (iii) shares for which vesting was accelerated as a result of the change in control provisions in the Approved Option Scheme, Unapproved Option Scheme, Performance Share Plan and International Performance Share Plan and as a result of entering into the Co-operation Agreement.
In addition, several of the executive officers are entitled to severance compensation pursuant to executive employment agreements as their employment was terminated on the effective date of the Combination. Furthermore, employees of Pace are eligible to receive a retention bonus if the employee stays for a period of 90 days after the Combination has been consummated. These charges are recognized as a post-combination expense. As of the closing date of the Combination, it is estimated and expected that New ARRIS will recognize post-combination compensation expense of approximately $11.4 million. This severance compensation and the retention bonus have been excluded from the unaudited pro forma condensed combined financial information as it reflects charges directly attributable to the Combination that will not have a continuing impact on New ARRIS’ operations.
Pursuant to the Merger Agreement, at the effective time of the Merger between ARRIS and New ARRIS, each outstanding ARRIS Option, ARRIS Restricted Share, ARRIS RSU and ARRIS ESPP, subject to applicable law, was converted into a New ARRIS Option, New ARRIS Restricted Share, New ARRIS RSU or New ARRIS ESPP, respectively. The converted awards related to a number of New ARRIS shares equal to the number of ARRIS shares subject to the corresponding pre-conversion award and will continue to have, subject to applicable law and the accelerated vesting described below, the same terms and conditions that were applicable to the corresponding pre-conversion ARRIS award (including settlement in cash or shares, as applicable). This conversion did not result in incremental value to the share/option holders. In addition, non-employee directors and executive officers of ARRIS have certain interests in the Combination that include accelerated vesting of certain outstanding equity awards (intended to avoid excise tax becoming due on such equity awards), continuing non-employee director and executive officer positions with New ARRIS, and rights to ongoing indemnification and insurance coverage.
On June 18, 2015, ARRIS, ARRIS Enterprises, Inc., New ARRIS and certain ARRIS subsidiaries, as borrowers, and Bank of America, N.A., as administrative agent, swing line lender and line of credit lender and the other lender parties thereto entered into the Credit Agreement, which amends and restates ARRIS’ Existing Credit Agreement. The Credit Agreement provides for senior secured credit facilities comprised of (i) a “U.S. Revolving Credit Facility” of $14 million, (ii) a “Multicurrency Revolving Credit Facility” of $486 million, (iii) a “Term Loan A Facility” of $990 million, (iv) a delayed draw “Term A-1 Loan Facility” of $800 million and (v) a “Term Loan B Facility” of $543.8 million. Funding of the Term Loan A Facility refinanced the term loan A facility under the Existing Credit Agreement while the Term Loan B Facility is a continuation of the term loan B facility under the Existing Credit Agreement. Funding of the Term A-1 Loan Facility under the Credit Agreement occurred at the closing of the Combination. The proceeds of the loans under the Term A-1 Loan Facility were used to finance: (i) the payment of the cash consideration by New ARRIS to holders of Pace shares being acquired by New ARRIS in the Combination; (ii) the payment of cash consideration to holders of options or awards to acquire Pace shares pursuant to any proposal under the Takeover Code, (iii) the fees, costs and expenses related to the Combination and issuance of new debt, refinancing, prepayment, repayment, redemption, discharge, defeasance and/or amendment of all existing debt of Pace and (iv) the payment of existing debt at Pace, which was paid subsequent to the Combination.
31
Although ARRIS uses derivative instruments to manage its interest rate and foreign currency exposure, including the cash portion of the consideration, no pro forma adjustments have been reflected in the unaudited pro forma condensed combined financial information with respect to any changes to derivative instruments that have occurred in connection with the Combination or the Financing.
2. Basis of Presentation
The unaudited pro forma condensed combined financial information was prepared in accordance with U.S. GAAP and pursuant to SEC Regulation S-X Article 11, and presents the pro forma financial position and results of operations of the combined companies based upon the historical information after giving effect to the Combination, the Financing and adjustments described in these notes. The unaudited pro forma condensed combined balance sheet is presented as if the Combination and the incurrence of $800 million of indebtedness under Term A-1 Loan Facility had occurred on September 30, 2015; and the unaudited pro forma condensed combined statements of operations for the year ended December 31, 2014 and the nine-month period ended September 30, 2015 are presented as if the Combination and Financing had occurred on January 1, 2014.
The historical results of ARRIS have been derived from its financial statements contained in its Annual Report on Form 10-K for the year ended December 31, 2014 and ARRIS’ unaudited consolidated financial statements and related notes thereto contained in its Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2015. The historical results of Pace for the year ended December 31, 2014 have been derived from its audited financial statements which have been included in Exhibit 99.1 to the Form 8-K/A, and the historical financial information as of and for the six months ended June 30, 2015 have been derived from unaudited financial information, which have been included in Exhibit 99.2 to the Form 8K/A. The historical financial information of Pace has been prepared in accordance with IFRS as issued by the IASB. Identified measurement differences in accounting principles between IFRS and U.S. GAAP as they apply to Pace have been adjusted to reflect such results in accordance with U.S. GAAP. See Note 4, “Pace — IFRS to U.S. GAAP Adjustments.” Adjustments have also been made to conform Pace’s significant accounting policies to ARRIS’ accounting policies. See Note 3, “Conforming Accounting Policies and Reclassification Adjustments.”
The Combination is reflected in the unaudited pro forma condensed combined financial information as being accounted for under the acquisition method in accordance with ASC 805, Business Combinations, with ARRIS treated as the accounting acquirer. Under the acquisition method, the total estimated purchase price is calculated as described in Note 5. In accordance with ASC 805, the assets acquired and the liabilities assumed have been measured at preliminary estimates of fair value. These preliminary estimates are based on key assumptions related to the Combination and have been developed using publicly disclosed information for other acquisitions in the industry, ARRIS’ historical experience and current available data.
Under ASC 805, acquisition-related transaction costs and acquisition-related restructuring charges are not included as components of consideration transferred but are accounted for as expenses in the period in which the costs are incurred. For the nine months ended September 30, 2015 and for the nine months ended June 30, 2015, ARRIS and Pace incurred approximately $16.5 million and $2.8 million, respectively, of Combination-related costs. These costs are considered to be directly related to the Combination and are not expected to have a continuing impact and therefore have been excluded from the unaudited pro forma statement of operations.
The unaudited pro forma condensed combined financial information does not reflect ongoing cost savings that ARRIS expects to achieve as a result of the Combination or the costs necessary to achieve these costs savings or synergies.
32
3. Conforming Accounting Policies and Reclassification Adjustments
ARRIS performed certain procedures for the purpose of identifying any material differences in significant accounting policies between ARRIS and Pace, and any accounting adjustments that would be required in connection with adopting uniform policies. Procedures performed by ARRIS to identify material adjustments involved a review of Pace’s significant accounting policies, including those disclosed in Pace’s Annual Report for the year ended December 31, 2014, and discussion with Pace management regarding Pace’s significant accounting policies.
Additionally, the historical consolidated financial information of Pace presented herein has been adjusted by condensing certain line items and by reclassifying certain line items in order to conform to ARRIS’ financial statement presentation; these reclassifications are reflected in the column “Accounting Policies and Reclassifications.”
The reclassification adjustments on the unaudited pro forma balance sheet pertain to the following:
• | Trade and other receivables have been reclassified into accounts receivable, prepaids and other receivables; |
• | Trade and other payables have been reclassified into accounts payable, accrued compensation, benefits and related taxes, deferred revenue and other accrued liabilities; |
• | Other accrued current liabilities have been reclassified into accrued warranty for warranty provisions less than one year, deferred revenue, and accrued compensation, benefits and related taxes; and |
• | Royalty accruals from accounts payables have been reclassified to other accrued liabilities. |
The reclassification adjustments on the unaudited pro forma statements of operations include the reclassification of foreign exchange gains and losses from cost of sales and other expense to loss (gain) on foreign currency.
4. Pace — IFRS to U.S. GAAP Adjustments
The unaudited pro forma condensed combined financial information includes information from (1) historical audited financial statements of Pace for the year ended December 31, 2014 and (2) historical unaudited financial information for the nine months ended June 30, 2015, prepared using IFRS, which have been adjusted to reflect Pace’s consolidated financial statements on a U.S. GAAP basis consistent with ARRIS. The adjustments to U.S. GAAP (which are unaudited) are as follows (in thousands):
U.S. GAAP Adjustment Reference | ||||||||||||||||||||||||||||||||||||||||
Balance Sheet Line Item | (1) | (2) | (3) | (4) | (5) | (6) | (7) | (8) | (9) | Total U.S. GAAP Adj. | ||||||||||||||||||||||||||||||
Accounts receivable (net of allowances for doubtful accounts) | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | — | $ | 21,959 | $ | — | $ | 21,959 | ||||||||||||||||||||
Current deferred income tax assets | — | — | 1,426 | 4,614 | 200 | 22,953 | 516 | — | 11,146 | 40,855 | ||||||||||||||||||||||||||||||
Intangible assets (net of accumulated amortization) | (87,850 | ) | — | — | — | — | — | — | — | — | (87,850 | ) | ||||||||||||||||||||||||||||
Noncurrent deferred income tax assets | — | — | 582 | 3,624 | — | (25,392 | ) | — | — | — | (21,186 | ) | ||||||||||||||||||||||||||||
Other current assets | — | — | — | — | — | — | — | — | 83,937 | 83,937 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total Assets | (87,850 | ) | — | 2,008 | 8,238 | 200 | (2,439 | ) | 516 | 21,959 | 95,083 | 37,715 | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Deferred revenue | — | — | 5,021 | 20,596 | — | — | — | — | 114,060 | 139,677 | ||||||||||||||||||||||||||||||
Current income taxes liability | — | — | — | — | (7,605 | ) | 421 | — | — | — | (7,184 | ) | ||||||||||||||||||||||||||||
Current portion of long-term debt and financing lease obligations | — | — | — | — | — | — | — | 21,959 | — | 21,959 | ||||||||||||||||||||||||||||||
Other accrued liabilities | — | (43,700 | ) | — | — | — | — | — | — | — | (43,700 | ) | ||||||||||||||||||||||||||||
Noncurrent income tax liability | — | — | — | — | 9,055 | — | — | — | — | 9,055 | ||||||||||||||||||||||||||||||
Noncurrent deferred income tax liabilities | (12,030 | ) | 7,238 | — | — | (1,250 | ) | (4,683 | ) | (232 | ) | — | — | (10,957 | ) | |||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total Liabilities | (12,030 | ) | (36,462 | ) | 5,021 | 20,596 | 200 | (4,262 | ) | (232 | ) | 21,959 | 114,060 | 108,850 | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Capital in excess of par value | — | — | — | — | — | — | 1,887 | — | — | 1,887 | ||||||||||||||||||||||||||||||
Retained earnings | (76,268 | ) | 36,462 | (3,013 | ) | (12,358 | ) | — | 1,823 | (1,139 | ) | — | (18,977 | ) | (73,470 | ) | ||||||||||||||||||||||||
Accumulated other comprehensive loss | 448 | — | — | — | — | — | — | — | — | 448 | ||||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||||||
Total Liabilities and Stockholders’ Equity | $ | (87,850 | ) | $ | — | $ | 2,008 | $ | 8,238 | $ | 200 | $ | (2,439 | ) | $ | 516 | $ | 21,959 | $ | 95,083 | $ | 37,715 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
33
For the year ended December 31, 2014
U.S. GAAP Adjustments | ||||||||||||||||||||||||||||
1 | 2 | 3 | 4 | 7 | 9 | Total US GAAP Adjustments | ||||||||||||||||||||||
Net Sales | $ | — | $ | — | $ | 2,670 | $ | (1,589 | ) | $ | — | $ | (91,936 | ) | $ | (90,855 | ) | |||||||||||
Cost of sales | — | (7,787 | ) | — | — | — | (65,532 | ) | (73,319 | ) | ||||||||||||||||||
Research and development expenses | 20,760 | — | — | — | — | — | 20,760 | |||||||||||||||||||||
Income tax expense (benefit) | (480 | ) | (1,206 | ) | 934 | (556 | ) | 750 | (9,769 | ) | (10,327 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Net income (loss) | $ | (20,280 | ) | $ | 8,993 | $ | 1,736 | $ | (1,033 | ) | $ | (750 | ) | $ | (16,635 | ) | $ | (27,969 | ) | |||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the nine months ended September 30, 2015
U.S. GAAP Adjustments | ||||||||||||||||||||||||||||||||
1 | 2 | 3 | 4 | 6 | 7 | 9 | Total US GAAP Adjustments | |||||||||||||||||||||||||
Net Sales | $ | — | $ | — | $ | 1,294 | $ | 2,363 | $ | — | $ | — | $ | (95,758 | ) | $ | (92,101 | ) | ||||||||||||||
Cost of sales | — | (5,504 | ) | — | — | — | — | (71,412 | ) | (76,916 | ) | |||||||||||||||||||||
Research and development expenses | 8,013 | — | — | — | — | — | — | 8,013 | ||||||||||||||||||||||||
Income tax expense (benefit) | 100 | (238 | ) | 502 | 773 | (134 | ) | (1,916 | ) | (9,008 | ) | (9,921 | ) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||||
Net income (loss) | $ | (8,113 | ) | $ | 5,742 | $ | 792 | $ | 1,590 | $ | 134 | $ | 1,916 | $ | (15,338 | ) | $ | (13,277 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) | Research and development activities — Adjustment reflects the research and product development expenses that are expensed as incurred in accordance with U.S. GAAP. Under IFRS, Pace capitalizes certain development costs which are amortized over a period between six and 30 months depending on the nature of the development project. |
(2) | Royalty provisions — Adjustment reflects the reversal of the previously recognized loss contingencies to reflect the difference in the definition of probable between IFRS and U.S. GAAP. |
(3) | Deferral of revenue for post contract support — Adjustment reflects an increase to net sales resulting from the additional revenue recognized from the prior period’s deferred revenue balance in accordance with U.S. GAAP partially offset by the revenue previously recognized under IFRS that would otherwise be deferred in accordance with U.S. GAAP. |
(4) | Deferral of software and services revenues for professional services and licenses — Adjustment reflects the revenue previously recognized under IFRS that would otherwise be deferred in accordance with U.S. GAAP. |
(5) | Uncertain tax positions — Adjustment reflects the reclassification of uncertain tax positions between deferred and current tax accounts. |
34
(6) | Deferred tax assets and liabilities classification — Adjustment reflects the reclassification of deferred tax assets and liabilities as current or noncurrent based on the nature of the related asset or liability in accordance with U.S. GAAP. |
(7) | Deferred tax and equity impact of stock based compensation — Adjustment reflects the differences in calculating the deferred tax assets for share-based payment arrangements related to exercised options. |
(8) | Transfer of receivables — Adjustment reflects the reversal of previously derecognized receivables under IFRS as the transfer of receivables is accounted for as a secured borrowing under U.S. GAAP. |
(9) | Deferral of profit recognized in connection with certain distributor sales – Adjustment reflects the revenue and related cost of sales previously recognized under IFRS that would otherwise be deferred in accordance with U.S. GAAP under sell-through approach. |
5. Preliminary Consideration Transferred and Preliminary Fair Value of Net Assets Acquired
The Combination has been accounted for using the acquisition method of accounting in accordance with ASC 805, which requires, among other things, that the assets acquired and liabilities assumed be recognized at their acquisition date fair values, with any excess of the consideration transferred over the estimated fair values of the identifiable net assets acquired recorded as goodwill. In addition, ASC 805 establishes that the common stock issued to effect the Combination be measured at the closing date of the Combination at the then-current market price.
The total consideration transferred is based on (1) the opening price of ARRIS’ common stock of $30.08 per share on January 4, 2016 (the date of the Combination), (2) the number of Pace shares outstanding as of January 4, 2016, and (3) the number of Pace stock options, deferred shares and performance shares at January 4, 2016. Using the assumptions above, the total consideration approximated $2,073.5 million. At the effective time, each outstanding Pace share was cancelled and converted into the right to receive (1) 132.5 pence in cash, without interest, (converted to $1.95 at an exchange rate of 1.4707 as of January 4, 2016) and (2) 0.1455 New ARRIS shares.
The preliminary estimate of the consideration to be paid by ARRIS in the Combination is as follows (in thousands):
Cash Consideration | $ | 638,789 | ||
Stock Consideration | 1,434,690 | |||
|
| |||
Total consideration transferred | $ | 2,073,479 | ||
|
|
Below is the summary of the cash and stock consideration (in thousands, except share information):
Number of Pace shares | Number of ARRIS shares | Cash consideration (1) | Stock consideration (2) | Total consideration | ||||||||||||||||
Total Consideration Transferred | 327,806,276 | 47,695,813 | $ | 638,789 | $ | 1,434,690 | $ | 2,073,479 |
(1) | Cash consideration represents the cash payment of 132.5 pence (converted to $1.95 at an exchange rate of 1.4707) for each of Pace’s shares and equity awards outstanding. |
(2) | Stock consideration represents the conversion of each of Pace’s shares and equity awards outstanding at a conversion rate of 0.1455 with a value of $30.08 at January 4, 2016. |
35
The following is a summary of the preliminary estimated fair values of the net assets acquired (in thousands):
Total estimated consideration transferred | $ | 2,073,479 | ||
|
| |||
Cash and cash equivalents | 254,162 | |||
Accounts and other receivables | 593,605 | |||
Inventories | 271,227 | |||
Prepaids | 17,255 | |||
Current deferred income tax assets | 40,855 | |||
Other current assets | 83,937 | |||
Property, plant and equipment | 98,371 | |||
Intangible assets | 1,100,000 | |||
Noncurrent deferred income tax assets | 6,302 | |||
Accounts payable and other current liabilities | (603,661 | ) | ||
Deferred revenue | (21,344 | ) | ||
Short-term borrowings | (21,959 | ) | ||
Current income taxes liability | (3,544 | ) | ||
Other accrued liabilities | (150,588 | ) | ||
Long-term debt and financing lease obligations | (256,477 | ) | ||
Other noncurrent liabilities | (444,774 | ) | ||
|
| |||
Net assets acquired | 963,367 | |||
|
| |||
Goodwill | $ | 1,110,112 | ||
|
|
ARRIS has not yet completed the detailed valuation work necessary to arrive at the required estimates of the fair value of Pace assets acquired and liabilities assumed. ARRIS anticipates that the valuations of the acquired assets and liabilities will include, but not be limited to inventory, property, plant, and equipment, customer contracts and relationships, technology and patents and other intangibles, and deferred revenue. The valuations will consist of physical appraisals, discounted cash flow analyses, or other appropriate valuation techniques to determine the fair value of the assets acquired and liabilities assumed. For purposes of the unaudited pro forma condensed combined financial information, it is assumed that the book value approximates fair value for current assets and current liabilities, except for inventories, deferred revenue and other accrued liabilities as described in Note 6(b), Note 6(g) and Note 6(i), respectively.
The final consideration, and amounts allocated to assets acquired and liabilities assumed in the Combination, could differ materially from the preliminary amounts presented in the unaudited pro forma condensed combined financial information. A decrease in the fair value of assets acquired or an increase in the fair value of liabilities assumed in the Combination from those preliminary valuations presented in the unaudited pro forma condensed combined financial information would result in a dollar-for-dollar corresponding increase in the amount of goodwill that will result from the Combination. In addition, if the value of the acquired assets is higher than the preliminary indication, it may result in higher amortization and depreciation expense than is presented in the unaudited pro forma condensed combined financial information.
6. Preliminary Pro Forma Adjustments
The preliminary pro forma adjustments included in the unaudited pro forma condensed combined financial information related to the Combination and Financing are as follows:
(a) Cash and cash equivalents —Adjustment reflects the preliminary net adjustment to cash in connection with the Combination (in thousands):
Cash portion of Combination Consideration (i) | $ | (638,789 | ) | |
Payment of transaction related expenses (ii) | (31,342 | ) | ||
New ARRIS Term A-1 Facility (iii) | 800,000 | |||
|
| |||
Pro forma adjustment to cash and cash equivalents | $ | 129,869 | ||
|
|
36
Components of the adjustment include (i) a decrease in cash resulting from the payment of the cash component of the Combination consideration, including cash related to the payment to holders of Pace stock options, deferred shares and performance shares, of which $22.3 million relates to Combination consideration; (ii) a decrease in cash related to the estimated transaction related expenses of $31.3 million, consisting of financing fees of $3.4 million, of which an estimated $2.3 million will be capitalized, and advisory costs of $28.0 million expected to be expensed as incurred in connection with the Combination; and (iii) an increase in cash resulting from the proceeds in additional borrowings of an aggregate amount of $800.0 million for the Financing.
(b) Inventories —Adjustment reflects the preliminary estimated fair value adjustment of $33.6 million to inventory acquired in the Combination. As the raw materials inventory was assumed to be at market value, the preliminary adjustment is related to work-in-process and finished goods inventory. The preliminary fair value of work-in-process inventory considered costs to complete inventory and estimated profit on these costs. The preliminary fair value of finished goods inventory to be acquired in the Combination was determined based on an analysis of estimated future selling prices, costs of selling effort, and profit on selling effort. The unaudited pro forma combined statements of operations do not reflect the impact of this preliminary inventory increase in cost of sales as such amounts are directly attributable to the Combination and will not have a continuing impact on the combined results.
(c) Property, plant and equipment —Adjustment reflects the preliminary fair market value of property, plant and equipment acquired in the Combination. The preliminary amounts assigned to property, plant and equipment are as follows (in thousands):
Buildings and Leasehold Improvements | $ | 8,361 | ||
Machinery and Equipment | 87,801 | |||
Construction in Progress | 2,209 | |||
|
| |||
Total estimated preliminary fair value of property, plant and equipment | 98,371 | |||
Less: Pace book value of property, plant and equipment | (57,813 | ) | ||
|
| |||
Pro forma adjustment to property, plant and equipment | $ | 40,558 | ||
|
|
(d) Goodwill —Adjustment reflects the preliminary estimated adjustment to goodwill as a result of the Combination. Goodwill represents the excess of the consideration transferred over the preliminary fair value of the assets acquired and liabilities assumed as described in Note 5. The goodwill is attributable to the expected synergies of the combined business operations, new growth opportunities, and the acquired assembled and trained workforce of Pace. The goodwill is not expected to be deductible for tax purposes. The preliminary pro forma adjustment to goodwill is calculated as follows (in thousands):
Consideration transferred | $ | 2,073,479 | ||
Less: Fair value of net assets to be acquired | (963,367 | ) | ||
|
| |||
Total estimated goodwill | 1,110,112 | |||
Less: Pace book value of goodwill | (464,806 | ) | ||
|
| |||
Pro forma adjustment to goodwill | $ | 645,306 | ||
|
|
(e) Intangible assets —Adjustment reflects the preliminary fair market value related to identifiable intangible assets acquired in the Combination. The preliminary fair market value was determined using a market approach. The preliminary amounts assigned to the identifiable intangible assets are as follows (in thousands):
Customer Contracts and Relationships | $ | 400,000 | ||
Technology and Patents | 650,000 | |||
Other | 50,000 | |||
|
| |||
Total estimated preliminary fair value of intangible assets | 1,100,000 | |||
Less: Pace book value of intangible assets | (184,200 | ) | ||
|
| |||
Pro forma adjustment to intangible assets | $ | 915,800 | ||
|
|
37
(f) Other assets —As of September 30, 2015, ARRIS incurred an estimated $2.3 million in capitalizable debt issuance costs in conjunction with the Financing for the Term A-1 Loan that was funded upon the closing of the Combination. Of this $2.3 million, $1.4 million represents deferred financing fees and will be capitalized as other assets on the balance sheet and amortized over the life of the underlying debt instrument. The remaining $0.9 million represents original issuance discount for the Term A-1 Loan and is presented as a pro forma adjustment to reclassify the original issuance discount from other assets to long-term debt.
(g) Deferred revenue —Adjustment reflects a reduction of $122.3 million related to the preliminary valuation of Pace’s historical deferred revenue balance assumed in the Combination. ARRIS will record the assumed deferred revenue at its acquisition date fair values. The process of determining the fair value of deferred revenue may result in a significant downward adjustment. The revenues associated with this reduction will not be recognized by ARRIS.
(h) Current income taxes liability – In accordance with the Merger Agreement and as a condition to closing the Merger, prior to closing the Merger, ARRIS Holdings transferred the shares of ARRIS Financing II SARL (“ARRIS Lux”) to New ARRIS. Under U.S. tax law, based on the best available information, New ARRIS believes the transfer of ARRIS Lux constituted a deemed distribution from ARRIS Holdings to New ARRIS that is treated as a dividend for U.S. tax purposes. A deemed dividend of this type is subject to U.S. withholding tax to the extent of the current and accumulated earnings and profits (as computed for tax purposes) (“E&P”) of ARRIS Holdings Inc., which include the E&P of the former ARRIS Group, Inc. and subsidiaries through December 31, 2016. Accordingly, ARRIS Holdings remitted U.S. withholding tax in the amount of $55 million based upon its estimated E&P of $1.1 billion and the U.S. dividend withholding tax rate of 5 percent (as provided in Article 10 (Dividends) of the United Kingdom-United States Tax Treaty).
(i) Other accrued liabilities —Adjustment reflects (i) an estimated $19.2 million of Combination related fees and expenses expected to be assumed by New ARRIS, which are payable subsequent to the closing of the Combination, and (ii) the current deferred tax liabilities related to the fair value adjustment of inventory, deferred revenue, acceleration of restricted stock for ARRIS executives, and the Combination related fees and expenses. Refer to adjustment (k) below for additional information regarding current deferred income tax liabilities.
(j) Current and long-term debt —To fund transaction-related items, the cash portion of the Combination consideration and other one-time costs, New ARRIS incurred upon the closing of the Combination $800.0 million of additional debt under the Term A-1 Loan Facility with a maturity of five years and an annual interest rate of LIBOR plus 1.75 basis points on the principal amount of the debt. In addition, in connection with the Term A-1 Loan Facility, ARRIS modified the terms of its existing Term Loan A Facility to extend the term to five years. Refer to adjustment (r) below for additional information regarding pro forma interest expense.
The preliminary adjustment to long-term debt is as follows (in thousands):
Proceeds from Term Loan A-1 Facility | $ | 800,000 | ||
Less: Proceeds from Debt Financing to be repaid within one year | (40,000 | ) | ||
Less: Original issuance discount, excluding $0.7 million to be amortized within one year | (2,547 | ) | ||
|
| |||
Pro forma adjustment to long-term debt | $ | 757,453 | ||
|
|
38
The preliminary adjustment to current portion of long-term debt is as follows (in thousands):
Proceeds from Term A-1 Loan to be repaid within one year | $ | 40,000 | ||
Less: Original issuance discount to be amortized within one year | (696 | ) | ||
|
| |||
Pro forma adjustment to Debt payments due within one year | $ | 39,304 | ||
|
|
(k) Deferred income taxes —Management estimated the tax rate at 29.0% which approximates a blended statutory tax rate for the tax jurisdictions where assets acquired and liabilities assumed reside. Adjustment reflects the deferred income tax effects of the preliminary pro forma adjustments made to the pro forma balance sheet, primarily as indicated in the table below (in thousands):
Adjustment to Asset Acquired (Liability Assumed) | Current Deferred Tax Liability(1) | Noncurrent Deferred Tax Liability | ||||||||||
Estimated fair value adjustment of identifiable intangible assets acquired | $ 915,800 | $ — | $ 265,582 | |||||||||
Estimated fair value adjustment of property, plant and equipment acquired | 40,558 | — | 11,762 | |||||||||
Estimated fair value adjustment of inventory acquired | 33,600 | 9,744 | — | |||||||||
Estimated fair value adjustment of deferred revenue assumed | (122,349 | ) | 35,481 | — | ||||||||
Estimated tax impact of post-combination compensation expense related to the acceleration of restricted stock for ARRIS executives upon completion of the Combination | N/A | (1,987 | ) | — | ||||||||
Estimated tax impact of Combination related fees and expenses expensed in connection with the Combination | N/A | (3,808 | ) | — | ||||||||
|
|
|
| |||||||||
Deferred tax liabilities related to estimated fair value adjustments | $ 39,430 | $ 277,344 | ||||||||||
|
|
|
|
(1) | Current deferred tax liabilities related to the fair value adjustment of inventory, deferred revenue, acceleration of restricted stock for ARRIS executives, and the Combination related fees and expenses are reflected in Other accrued liabilities in the unaudited pro forma balance sheet. |
(l) Stockholders’ equity —Adjustment reflects (i) the issuance of 47.7 million New ARRIS shares to shareholders of Pace; (ii) the elimination of the historical equity balances of Pace; (iii) the cancelation of treasury stock; (iv) the pro forma reduction to retained earnings of $25.2 million to reflect the estimated Combination related fees and expenses expected to be incurred upon completion of the Combination ($29.0 million expected to be expensed, net of $3.8 million tax benefit); (v) the pro forma reduction to retained earnings of $4.9 million to reflect the estimated post-combination compensation expense associated with the acceleration of restricted stock for ARRIS executive officers ($6.9 million expected to be expensed in connection with the Combination, net of $2.0 million tax benefit); and estimated withholding tax of $55.0 million on deemed dividends in connection with the Combination (refer to adjustment (h) above).
The preliminary unaudited pro forma adjustment to common stock is calculated as follows (in thousands):
Common stock from Combination (47,695,813) shares of New ARRIS common stock issued at par value of £0.01) | $ | 701 | ||
Common stock of New ARRIS (181,900,000 shares issued at par value of £0.01) | 856 | |||
Less: Pace historical common stock | (29,528 | ) | ||
|
| |||
Pro forma adjustment to common stock | $ | (27,971 | ) | |
|
|
39
The preliminary unaudited pro forma adjustment to capital in excess of par is calculated as follows (in thousands):
Capital in excess of par from Combination (47,695,813 shares issued at $30.08) | $ | 1,433,989 | ||
ARRIS unrecognized compensation expense for the acceleration of restricted stock for ARRIS executives upon completion of the Combination | 6,851 | |||
Less: Treasury stock cancelled as part of the Combination | (331,329 | ) | ||
Less: Capital in excess of par from conversion to New ARRIS | (856 | ) | ||
Less: Pace historical capital in excess of par | (198,319 | ) | ||
|
| |||
Pro forma adjustment to capital in excess of par | $ | 910,336 | ||
|
|
The preliminary unaudited pro forma adjustment to treasury stock is calculated as follows (in thousands):
Treasury stock cancelled as part of the Combination | 331,329 | |||
|
| |||
Pro forma adjustment - treasury stock | $ | 331,329 | ||
|
|
The preliminary unaudited pro forma adjustment to retained earnings is calculated as follows (in thousands):
Estimated Combination related fees and expenses of $29.0 million expected to be incurred upon completion of the Combination, net of tax of $3.8 million | $ (25,230) | |||
Estimated post combination expense of $6.9 million related to the acceleration of restricted stock for ARRIS executives upon completion of the Combination, net of tax of $2.0 million | (4,864) | |||
Estimated withholding tax of $55.0 million on deemed dividends in connection with the Combination | (55,000) | |||
Less: Pace historical retained earnings | (522,144) | |||
|
| |||
Pro forma adjustment to retained earnings | $ (607,238) | |||
|
|
The estimated fees and expenses have been excluded from the unaudited pro forma condensed combined statements of operations as they reflect charges directly attributable to the Combination that will not have a continuing impact on ARRIS’ operations.
The preliminary unaudited pro forma adjustment to accumulated other comprehensive loss eliminates Pace’s historical accumulated other comprehensive loss of $92.4 million.
(m) Cost of sales — Adjustment reflects the preliminary depreciation expense to be recorded in cost of sales of $0.1 million and $0.2 million for the year ended December 31, 2014 and nine months ended September 30, 2015, respectively, associated with the fair value of property, plant and equipment acquired in the Combination.
The preliminary depreciation expense for property, plant and equipment acquired from Pace is as follows (in thousands):
Property, plant and equipment | Estimated weighted average useful life (years) | Preliminary fair value | Depreciation expense for the year ended December 31, 2014 | Depreciation expense for the nine months ended September 30, 2015 | ||||||||||
Buildings and Leasehold Improvements | 9 | $ 8,361 | $ 929 | $ 697 | ||||||||||
Machinery and Equipment | 3 - 4 | 87,801 | 27,784 | 20,838 | ||||||||||
Construction in progress | - | 2,209 | — | — | ||||||||||
|
|
|
|
|
| |||||||||
Total estimated preliminary fair value of property, plant and equipment | $ 98,371 | 28,713 | 21,535 | |||||||||||
Less: Pace historical depreciation expense | (29,000 | ) | (20,800 | ) | ||||||||||
|
|
|
| |||||||||||
Pro forma adjustment to depreciation expense | $ (287 | ) | $ 735 | |||||||||||
|
|
|
|
Depreciation expense has been estimated based upon the nature of activities associated with the property, plant and equipment acquired. With other assumptions held constant, a 10% increase in the fair value adjustment for property, plant and equipment would increase annual pro forma depreciation expense by approximately $2.1 million. In addition, with other assumptions held constant, a one year change in the estimated useful lives of property, plant and equipment would change annual depreciation expense by approximately $7.2 million.
40
(n) Selling, general and administrative expenses — Adjustment reflects the preliminary depreciation expense to be recorded in selling, general and administrative expenses of $0.1 million and $0.2 million for the year ended December 31, 2014 and nine months ended September 30, 2015, respectively, associated with the fair value of property, plant and equipment acquired in the Combination. Refer to adjustment (m) above.
(o) Research and development expenses — Adjustment reflects the preliminary depreciation expense to be recorded in research and development expenses of $0.1 million and $0.3 million for the year ended December 31, 2014 and nine months ended September 30, 2015, respectively, associated with the fair value of property, plant and equipment acquired in the Combination. Refer to adjustment (m) above.
(p) Amortization of intangibles assets — Adjustment reflects the preliminary amortization expense associated with the fair value of the identifiable intangible assets acquired in the Combination of $143.5 million and $110.2 million for the year ended December 31, 2014 and the nine months ended September 30, 2015, respectively.
The preliminary amortization expense for the intangible assets acquired from Pace is as follows (in thousands):
Intangible assets | Estimated useful life (years) | Preliminary fair value | Amortization expense for the year ended December 31, 2014 | Amortization expense for the nine months ended September 30, 2015 | ||||||||||
Customer contracts and relationships | 7 | 400,000 | $ 61,538 | $ 46,154 | ||||||||||
Technology and Patents | 6 | 650,000 | 118,182 | 88,636 | ||||||||||
Other | 3 | 50,000 | 16,667 | 12,500 | ||||||||||
|
|
|
|
|
| |||||||||
Total | $1,100,000 | 196,387 | 147,290 | |||||||||||
|
| |||||||||||||
Less: Pace historical amortization expense | (52,936 | ) | (37,092 | ) | ||||||||||
|
|
|
| |||||||||||
Pro forma adjustment to amortization of intangible assets | $ 143,451 | $ 110,198 | ||||||||||||
|
|
|
|
The estimated fair value of amortizable intangible assets is expected to be amortized on a straight-line basis over the estimated useful lives. The amortizable lives reflect the periods over which the assets are expected to provide material economic benefit. With other assumptions held constant, a 10% increase in the fair value adjustment for amortizable intangible assets would increase annual pro forma amortization by approximately $19.6 million. In addition, with other assumptions held constant, a one year change in the estimated useful lives of customer contracts and relationships, technology and patents, and other intangible assets would change annual amortization expense by approximately $8.2 million, $18.2 million, and $4.2 million, respectively.
(q) Integration, acquisition, restructuring and other costs — Adjustment reflects the removal of Combination-related expenses of $2.8 million and $16.5 million incurred by Pace and ARRIS, respectively, as of June 30, 2015 and September 30, 2015. These expenses are considered to be directly related to the Combination and not expected to have a continuing impact on New ARRIS; therefore, these expenses have been excluded from the unaudited pro forma statement of operations.
(r) Interest expense — As described in Note 1, in connection with entering into the Co-operation Agreement, ARRIS entered into a Credit Agreement with various lenders pursuant to which the lenders agreed to amend and extend Term Loan A Facility and the Revolving Credit Facility, as well as enter into a new Term A-1 Loan Facility to fund part of the cash portion of the Combination consideration and fees and expenses in connection with the transactions contemplated by the Co-operation Agreement. For purposes of the unaudited pro forma condensed combined financial information, management assumed that the cash portion of the Combination consideration and transaction costs would be funded by the Financing.
41
The pro forma adjustment to interest expense reflects the (i) the removal of financing fees of $13.0 million incurred by ARRIS as of September 30, 2015, which are considered to be directly attributable to the Financing and not expected to have a continuing impact on New ARRIS and, therefore, have been excluded from the unaudited pro forma statement of operations; and (ii) additional interest expense that would have been incurred during the historical periods presented assuming the Combination and the Financing had occurred as of January 1, 2014.
The preliminary interest expense for the new debt incurred in connection with the Combination is as follows (in thousands):
Composition of new debt and related interest expense | Weighted Average Interest Rate (2) | Debt | Interest expense for the year ended December 31, 2014 | Interest expense for the nine months ended September 30, 2015 | ||||||||||||
Term A-1 Loan Facility(1) | 2.18 | % | $800,000 | $ 18,311 | $ 13,733 | |||||||||||
Amortization of new and existing ARRIS debt issuance costs | 9,605 | 6,877 | ||||||||||||||
|
|
|
| |||||||||||||
Total interest expense on new debt | 27,916 | 20,610 | ||||||||||||||
|
|
|
| |||||||||||||
Less: Reversal of Pace historical interest expense | (7,702 | ) | (5,834 | ) | ||||||||||||
Less: Reversal of ARRIS historical amortization of debt issuance costs | (9,035 | ) | (5,925 | ) | ||||||||||||
Less: Reversal of ARRIS debt issuance costs expense as incurred | — | (13,000 | ) | |||||||||||||
|
|
|
| |||||||||||||
Pro forma adjustment to interest expense | $ 11,179 | $ (4,149 | ) | |||||||||||||
|
|
|
|
(1) | The loan modification extended the term of the Term Loan A Facility to five years without change in principal balance. In addition, the borrowing capacity of the Revolving Credit Facility increased from $250 million to $500 million, all of which remains unused. Therefore, the interest expense only includes interest incurred on the principal balance of $800 million of Term A-1 Loan Facility and the unused commitment fee on the Revolving Credit Facility of 35 basis points. |
(2) | An increase (decrease) of 0.125% in the interest rate of Term A-1 Loan Facility and the incremental Revolving Credit Facility would increase (decrease) annual pro forma interest expense by $0.1 million. |
Debt issuance costs estimated to be incurred in conjunction with the Combination have been amortized over the term of the respective debt instrument for the purposes of calculating the net pro forma adjustment to interest expense.
(s) Income tax expense (benefit) — Adjustment reflects the income tax impacts of the pro forma adjustments made to the pro forma statement of operations, whereby management estimated the tax rate at 29.0% which approximates a blended statutory tax rate for the tax jurisdictions where the certain assets acquired and liabilities assumed reside.
42
(t) Basic and diluted net income per common share — The unaudited pro forma adjustment to shares outstanding used in the calculation of basic and diluted earnings per share is calculated as follows (in shares):
Year ended December 31, 2014 | Nine months ended September 30, 2015 | |||||||||||||||
Basic | Diluted | Basic | Diluted | |||||||||||||
New ARRIS shares to be issued to shareholders of Pace | 47,695,813 | 47,695,813 | 47,695,813 | 47,695,813 | ||||||||||||
New ARRIS shares to be issued to ARRIS executives related to the acceleration of restricted stock upon completion of the Combination | 1,009,643 | 420,203 | 1,009,643 | 327,447 | ||||||||||||
|
|
|
|
|
|
|
| |||||||||
New ARRIS shares to be issued | 48,705,456 | 48,116,016 | 48,705,456 | 48,023,260 | ||||||||||||
|
|
|
|
|
|
|
|
As all outstanding Pace shares will be eliminated in the Combination, the unaudited pro forma weighted average number of basic shares outstanding is calculated by adding ARRIS’ historical weighted average number of basic shares outstanding for the period and the number of New ARRIS shares expected to be issued to Pace’s shareholders in the Combination. The unaudited pro forma weighted average number of diluted shares outstanding is calculated by adding ARRIS’ historical weighted average number of diluted shares outstanding for the period and the number of New ARRIS shares expected to be issued in the Combination. Each outstanding stock option, deferred shares or performance shares issued under each of the Pace Share Plans, whether or not then vested or exercisable, will be canceled and terminated at the effective time in exchange for the right to receive New ARRIS shares.
43